Lipopolysaccharide (LPS) stimulates multiple signaling events, including nuclear factor-κB (NF-κB) activity and the mitogen-activated protein (MAP) kinases, ERK, JNK, and p38 in LPS-responsive cells, resulting in transcriptional activation and cytokine generation. LPS-induced signaling via toll-like receptor 4 (TLR4) results in the activation of the transcription factor NF-κB. Since LPS activates other signaling cascades in responsive cells, the objective of this study was to determine whether such events are mediated by TLR4 in response to LPS. We generated HEK293 cells that stably express TLR4 (HEK-TLR4) and examined their responsiveness to LPS by measuring NF-κB activity and production of interleukin-8 (IL-8). A trans-reporting system was used to measure the activity of Elk-1, an ETS-domain transcription factor targeted by MAP kinase pathways. LPS stimulated NF-κB reporter activity and IL-8 production, but not Elk-1 activity in HEK-TLR4 cells. When MD-2, a protein associated with the extracellular domain of TLR4, was expressed in these cells, there was a marked increase in Elk-1 activity, as well as ERK, JNK, and p38 MAP kinase phosphorylation in response to LPS. TLR4-mediated NF-κB reporter activity and IL-8 production was enhanced by the expression of MD-2. This study demonstrates that expression of both TLR4 and MD-2 is required in order for LPS to activate or augment the MAP kinase pathways, Elk-1 stimulation, and IL-8 generation.
INTRODUCTION
The pathophysiology of Gram-negative sepsis and septic shock is caused by lipopolysaccharide (LPS), a component of the outer membrane of bacteria, which can activate a variety of mammalian cell types, including monocytes and macrophages (1, 2) . This, in turn, causes the release of a number of proinflammatory mediators, such as interleukin (IL)-1, IL-6, IL-8, and tumor necrosis factor-α (1). Activation of LPSresponsive cells occurs rapidly after LPS interacts with circulating LPS binding protein and CD14, a glycosylphosphatidylinositol-linked cell surface or soluble protein necessary for efficient responses to LPS (2) . Evidence from studies in vitro indicates that expression of TLR2 and TLR4, two members of the toll-like receptor (TLR) family of cell-surface proteins, can enable the activation of nuclear factor-κB (NF-κB) and expression of genes for IL-1, IL-6, and IL-8 (3, 4) . TLR4 has been shown to mediate LPS-induced activation of NF-κB in HEK293 cells (5, 6) , while in 293T and Ba/F3 cells, TLR4-mediated responses to LPS requires the presence of MD-2, a cell-surface protein that associates with TLR4 (7) . Observations from studies with TLR2 and TLR4 knockout mice indicate that TLR4, but not TLR2, is necessary for responses to LPS under physiological conditions; TLR2 knockout mice respond normally to LPS, while TLR4 knockout mice or spontaneous TLR4 mutants (C3H/HeJ and C57/10ScCr) are not responsive to LPS (8) (9) (10) . On the other hand, studies with TLR2 knockout mice suggest that TLR2 has a broader recognition pattern than TLR4, which extends to a number of different bacterial cell wall components (10) .
LPS has been shown to initiate multiple intracellular signaling events, including the stimulation of pathways that lead to the activation of NF-κB and three distinct by guest on http://www.jbc.org/ Downloaded from 4 mitogen-activated protein (MAP) kinases, the ERK, p38, and JNK proteins (11) . TLR4-mediated NF-κB activation is thought to occur via a signaling pathway that is also utilized by IL-1 and IL-18 (12) . This pathway is activated by the interaction between myeloid differentiation protein (MyD88) with the receptor followed by stimulation of IL-1 receptor-associated kinase (IRAK) and subsequent recruitment of tumor necrosis factor receptor-associated factor-6 (TRAF6). Stimulation of these proximal signaling molecules results in the activation of members of the MAP kinase kinase kinase family that activate inhibitory kappa B (IκB) kinases (12) . IκB kinases can then phosphorylate IκB proteins that retain the rel-type transcription factor NF-κB in the cytosol, leading to ubiquitination and degradation of IκB proteins by the 26S proteosome, followed by release and nuclear translocation of NF-κB (13).
The proximal signaling molecules involved in LPS-induced activation of ERK, p38, and JNK are not well defined. LPS is thought to activate ERK1 and ERK2 proteins via the Ras/Raf-1/MEK1-2 pathway, JNK proteins via the MEKK-1/MKK4 pathway, and p38 proteins via activation of MKK3, respectively (14, 15) . These pathways are coupled to the production of certain proinflammatory cytokines, such as IL-8, by phosphorylating and activating the ternary complex Elk-1, resulting in increased levels of c-fos and enhanced formation of the transcription factor AP-1 (16) . The IL-8 promoter contains a NF-κB binding site that is necessary for activation, as well as AP-1 binding sites that, depending on the cell type, contribute to transcriptional activation (17, 18) . The aim of this study was to determine whether TLR4, which activates NF-κB in response to LPS 8
RESULTS
In order to study the role of TLR4 in LPS-stimulated signaling events, HEK293 cells expressing human TLR4 (HEK-TLR4) were generated and tested for LPS responsiveness after transfection with the NF-κB reporter construct, pELAM-luc, or an Elk-1 reporter system. Twenty-four hours post-transfection, cells were left untreated or incubated with 1 µg/ml LPS plus 10 nM sCD14 for an additional 6 h, at which time medium was collected to measure IL-8 production and the cells were lysed to determine luciferase activity in the supernatants. HEK-TLR4 cells respond to LPS/sCD14 treatment by elevating NF-κB reporter activity 10-fold above vector controls (Fig. 1A) . We have previously shown that this response to LPS is dependent on the presence of sCD14 (5).
The HEK-TLR4 cells also responded to LPS/sCD14 by secreting IL-8 ( Figure 1B ), a chemokine that elicits neutrophil chemotaxis and is regulated by NF-κB and AP-1 (17) . Superinduction of IL-8 by cycloheximide has been previously reported in bone marrowderived mononuclear cells (19) .
In contrast to NF-κB-driven gene expression (Figure 1 ), Elk-1 reporter activity was not affected by LPS/sCD14 in HEK-TLR4 cells, despite a robust increase in Elk-1 activity after EGF treatment (Figure 3 ). These results suggest either TLR4 does not mediate the LPS signals that result in Elk-1 stimulation or HEK293 cells lack other signaling molecules that are necessary for Elk-1 activation in response to LPS. MD-2 is a recently identified cell-surface protein that physically associates with TLR4 and is a requisite for LPS signaling to NF-κB in 293T and Ba/F3 cells (7) . We found that HEK-TLR4 cells do not express MD-2 as determined by RT-PCR (Fig. 4) . In contrast, MD-2 mRNA was detected in LPS-responsive cells, such as differentiated HL-60 monocytes and leukocytes (Fig. 4) . These data suggest that MD-2 may be the missing protein whose expression is required in order for LPS to stimulate Elk-1 reporter activity in HEK-TLR4 cells.
We co-transfected HEK-TLR4 cells with an pEFBOS expression vector encoding MD-2 cDNA and either pELAM-luc or an Elk-1 reporter system followed by the indicated treatment ( (28) . Based on the present and a previous study (29) , it appears that TLR4-MD-2 complex is capable of recognizing/sensing LPS with sCD14 better than LPS alone, or perhaps MD-2 is able to "lock" LPS on its binding site for a longer period of time. In the future, it will be important to understand the molecular interactions between TLR4 and other LPS signaling molecules that result in a cellular response. Continued identification and characterization of the mechanistic steps by which TLR4 and other TLRs mediate ligand-induced signals within the cell will enable further improvements in the discovery of anti-septic agents. 
